Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Jefferies Downgrades Imago BioSciences to Hold, Raises Price Target to $36

Jefferies analyst Maury Raycroft downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Hold and raises the price target from $35 to $36.

byBenzinga Newsdesk

November 22, 2022

1 minute read

Jefferies analyst Maury Raycroft downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Hold and raises the price target from $35 to $36.

Recap: Civista Bancshares Q4 Earnings

By Benzinga Insights

Today, 2:24 AM

Civista Bancshares (NASDAQ:CIVB) reported its Q4 earnings results on Friday, February 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

CIVB

Keybanc Maintains Overweight on Hub Group, Raises Price Target to $105

By Benzinga Newsdesk

Today, 2:24 AM

Keybanc analyst Todd Fowler maintains Hub Group (NASDAQ:HUBG) with a Overweight and raises the price target from $95 to $105.

HUBG

Why Are Insiders Buying Bed Bath & Beyond Stock For The First Time In 5 Months?

By Adam Eckert

Today, 2:24 AM

Bed Bath & Beyond Inc. (NASDAQ: BBBY) shares surged Thursday morning after several filings with the U.S. Securities and Exchange Commission (SEC) showed recent insider buying.

BBBY

Iridium Communications Q3 EPS $(0.02), Inline, Sales $162.16M Beat $153.71M Estimate

By Bill Haddad

Today, 2:24 AM

Iridium Communications (NASDAQ:IRDM) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 33.33 percent increase over losses of $(0.03) per share from the same period last

IRDM

Jefferies Downgrades Imago BioSciences to Hold, Raises Price Target to $36

Related Posts

Recap: Civista Bancshares Q4 Earnings

Keybanc Maintains Overweight on Hub Group, Raises Price Target to $105

Why Are Insiders Buying Bed Bath & Beyond Stock For The First Time In 5 Months?

Iridium Communications Q3 EPS $(0.02), Inline, Sales $162.16M Beat $153.71M Estimate